Renova Therapeutics   Report issue

For profit Phase 2 Phase 3
Founded: San Diego CA United States (2009)

Organization Overview

First Clinical Trial
2010
NCT00787059
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Renova Therapeutics

Active Ingredients

Drugs in Phase 3 Trials (1)

ad5.hac6 (2 trials)

Drugs in Phase 2 Trials (1)

sucrose (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Heart Failure (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 2
  • # of Trial APIs: 2